Patents by Inventor Nicole C. Dubois

Nicole C. Dubois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells and Cardiomyocyte Cells based on SIRPA Expression
    Publication number: 20200239848
    Abstract: The present invention relates to in vitro methods of enriching populations of human pluripotent stem cells that are induced to differentiate to cardiomyocyte progenitor cells and cardiomyocyte cells. The cell populations can be enriched by isolating cells that express SIRPA. The invention also related to in vitro-enriched populations of cardiomyocyte cells and cardiomyocyte progenitor cells obtained from populations of pluripotent stem.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Inventors: Gordon Keller, April M. Craft, Nicole C. Dubois
  • METHODS FOR ENRICHING PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTE PROGENITOR CELLS AND CARDIOMYOCYTE CELLS BASED ON SIRPA EXPRESSION
    Publication number: 20190322986
    Abstract: The present invention relates to in vitro methods of enriching populations of human pluripotent stem cells that are induced to differentiate to cardiomyocyte progenitor cells and cardiomyocyte cells. The cell populations can be enriched by isolating cells that express SIRPA. The invention also related to in vitro-enriched populations of cardiomyocyte cells and cardiomyocyte progenitor cells obtained from populations of pluripotent stem.
    Type: Application
    Filed: May 11, 2018
    Publication date: October 24, 2019
    Applicant: UNIVERSITY HEALTH NETWORK
    Inventors: Gordon Keller, April M. Craft, Nicole C. Dubois
  • Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression
    Patent number: 9994821
    Abstract: The present invention relates to in vitro methods of enriching populations of human pluripotent stem cells that are induced to differentiate to cardiomyocyte progenitor cells and cardiomyocyte cells. The cell populations can be enriched by isolating cells that express SIRPA. The invention also related to in vitro-enriched populations of cardiomyocyte cells and cardiomyocyte progenitor cells obtained from populations of pluripotent stem.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: June 12, 2018
    Assignee: UNIVERSITY HEALTH NETWORK
    Inventors: Gordon Keller, April M. Craft, Nicole C. Dubois
  • METHODS FOR ENRICHING PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTE PROGENITOR CELLS AND CARDIOMYOCYTE CELLS BASED ON SIRPA EXPRESSION
    Publication number: 20130230921
    Abstract: The present invention relates to methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on SIRPA expression.
    Type: Application
    Filed: August 26, 2011
    Publication date: September 5, 2013
    Applicant: University Health Network
    Inventors: Gordon Keller, April M. Craft, Nicole C. Dubois